etoposide has been researched along with Shock, Septic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Lu, Z; Xu, X; Yang, Y; Zhang, J; Zhang, P; Zhang, T; Zhao, H | 1 |
| Darmon, M; Fadllalah, J; Frapard, T; Mariotte, E; Valade, S | 1 |
| Ardeshna, K; Bailey, C; Dearden, C | 1 |
| Aoki, T; Arakawa, Y; Hanada, R; Hayashi, M; Koh, K; Kubota, Y; Mori, M; Oyama, R | 1 |
| Ding, X; Liu, B; Yang, J | 1 |
| Annechini, G; Cavalieri, E; De Angelis, F; Foà, R; Frattarelli, N; Gentilini, F; Grapulin, L; Mandelli, F; Matturro, A; Pulsoni, A; Sacco, M; Torelli, F; Vignetti, M | 1 |
| Aziz, A; Gosbell, IB; Sanghavi, R; Varghese, B | 1 |
| Carrascosa, JM; Ferrándiz, C; Guinovart, RM | 1 |
| Cha, YJ; Kim, HR; Kim, JW; Park, EK; Yu, N | 1 |
1 review(s) available for etoposide and Shock, Septic
| Article | Year |
|---|---|
Effect of early goal directed therapy in the treatment of severe sepsis and/or septic shock.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Goals; Health Resources; Humans; Methotrexate; Prospective Studies; Sepsis; Shock, Septic | 2016 |
1 trial(s) available for etoposide and Shock, Septic
| Article | Year |
|---|---|
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pericarditis; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2009 |
7 other study(ies) available for etoposide and Shock, Septic
| Article | Year |
|---|---|
Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K/Akt pathway.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; COVID-19 Drug Treatment; Disease Models, Animal; Down-Regulation; Etoposide; Female; Interleukin-10; Interleukin-6; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-maf; Shock, Septic; Topoisomerase II Inhibitors; Tumor Necrosis Factor-alpha; Up-Regulation | 2021 |
Acute circulatory failure in critically ill patients with hemophagocytic syndrome.
Topics: Adult; Critical Illness; Etoposide; Humans; Intensive Care Units; Lactates; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Norepinephrine; Retrospective Studies; Shock, Septic | 2022 |
Haemophagocytic lymphohistiocytosis as a consequence of untreated B-cell chronic lymphocytic leukaemia.
Topics: Dexamethasone; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Positron Emission Tomography Computed Tomography; Shock, Septic | 2017 |
Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia.
Topics: Adenine Nucleotides; Adolescent; Analgesics, Opioid; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Cefazolin; Child; Clofarabine; Cyclophosphamide; Etoposide; Fentanyl; Humans; Induction Chemotherapy; Male; Pain; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Shock, Septic; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2014 |
Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Methicillin-Resistant Staphylococcus aureus; Multiple Organ Failure; Pancytopenia; Shock, Septic; Staphylococcal Infections | 2010 |
[Leukemia cutis arising at the site of injection of a tetanus vaccine booster].
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Immunization, Secondary; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Leukosialin; Male; Middle Aged; Radiotherapy, Adjuvant; Shock, Septic; Skin; Tetanus Toxoid | 2010 |
Development of acute megakaryoblastic leukemia with isochromosome (12p) after a primary mediastinal germ cell tumor in Korea.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chromosomes, Human, Pair 12; Cisplatin; Etoposide; Humans; Isochromosomes; Karyotyping; Leukemia, Megakaryoblastic, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Republic of Korea; Shock, Septic | 2011 |